Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Cash from Operations (2021 - 2025)

PAVmed has reported Cash from Operations over the past 5 years, most recently at 1506000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 1506000.0 for Q4 2025, down 1702.13% from a year ago — trailing twelve months through Dec 2025 was 5206000.0 (up 85.75% YoY), and the annual figure for FY2025 was 5206000.0, up 84.48%.
  • Cash from Operations for Q4 2025 was 1506000.0 at PAVmed, down from 900000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for PAVM hit a ceiling of 94000.0 in Q4 2024 and a floor of 22558000.0 in Q2 2022.
  • Median Cash from Operations over the past 5 years was 11656000.0 (2024), compared with a mean of 10183631.58.
  • Biggest five-year swings in Cash from Operations: skyrocketed 100.79% in 2024 and later tumbled 1702.13% in 2025.
  • PAVmed's Cash from Operations stood at 16777000.0 in 2021, then decreased by 0.27% to 16823000.0 in 2022, then increased by 29.42% to 11874000.0 in 2023, then skyrocketed by 100.79% to 94000.0 in 2024, then tumbled by 1702.13% to 1506000.0 in 2025.
  • The last three reported values for Cash from Operations were 1506000.0 (Q4 2025), 900000.0 (Q3 2025), and 1200000.0 (Q2 2025) per Business Quant data.